Metronomic chemotherapy with cyclophosphamide plus low dose of corticosteroids in advanced castratio...
Metronomic chemotherapy with cyclophosphamide plus low dose of corticosteroids in advanced castration-resistant prostate cancer across the era of taxanes and new hormonal drugs
About this item
Full title
Author / Creator
Publisher
New York: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
The aim of our study is to investigate the efficacy of metronomic cyclophosphamide plus low dose of corticosteroids in advanced or metastatic castration-resistant prostate cancer (CRPC) before, between, and after standard chemotherapy, such as docetaxel and cabazitaxel, and new hormonal treatments, such as abiraterone and enzalutamide. A retrospect...
Alternative Titles
Full title
Metronomic chemotherapy with cyclophosphamide plus low dose of corticosteroids in advanced castration-resistant prostate cancer across the era of taxanes and new hormonal drugs
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_osti_scitechconnect_22938383
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_osti_scitechconnect_22938383
Other Identifiers
ISSN
1357-0560,1559-131X
E-ISSN
1559-131X
DOI
10.1007/s12032-019-1304-y
